DK1109806T3 - Komplekser af paroxetin med cyclodextriner eller cyclodextrinderivater - Google Patents

Komplekser af paroxetin med cyclodextriner eller cyclodextrinderivater

Info

Publication number
DK1109806T3
DK1109806T3 DK00940418T DK00940418T DK1109806T3 DK 1109806 T3 DK1109806 T3 DK 1109806T3 DK 00940418 T DK00940418 T DK 00940418T DK 00940418 T DK00940418 T DK 00940418T DK 1109806 T3 DK1109806 T3 DK 1109806T3
Authority
DK
Denmark
Prior art keywords
paroxetine
complexes
cyclodextrins
cyclodextrin derivatives
cyclodextrin
Prior art date
Application number
DK00940418T
Other languages
Danish (da)
English (en)
Inventor
Paolo Mascagni
Giuseppe Bottoni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI001459A external-priority patent/ITMI991459A1/it
Priority claimed from IT99MI002406 external-priority patent/IT1314232B1/it
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Application granted granted Critical
Publication of DK1109806T3 publication Critical patent/DK1109806T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK00940418T 1999-07-01 2000-06-30 Komplekser af paroxetin med cyclodextriner eller cyclodextrinderivater DK1109806T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI001459A ITMI991459A1 (it) 1999-07-01 1999-07-01 Complessi di sali di paroxetina con ciclodestrine
IT99MI002406 IT1314232B1 (it) 1999-11-17 1999-11-17 Complessi di paroxetina base con ciclodestrine o derivati delleciclodestrine.
PCT/EP2000/006121 WO2001002393A1 (fr) 1999-07-01 2000-06-30 Complexes de paroxetine, avec des cyclodextrines et des derives de la cyclodextrine

Publications (1)

Publication Number Publication Date
DK1109806T3 true DK1109806T3 (da) 2003-12-22

Family

ID=26331667

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00940418T DK1109806T3 (da) 1999-07-01 2000-06-30 Komplekser af paroxetin med cyclodextriner eller cyclodextrinderivater

Country Status (13)

Country Link
US (1) US6984632B1 (fr)
EP (1) EP1109806B8 (fr)
JP (1) JP2003503493A (fr)
KR (1) KR100759159B1 (fr)
AT (1) ATE248165T1 (fr)
AU (1) AU5535900A (fr)
BR (1) BR0006838A (fr)
CA (1) CA2341984A1 (fr)
DE (1) DE60004768T2 (fr)
DK (1) DK1109806T3 (fr)
ES (1) ES2206254T3 (fr)
PT (1) PT1109806E (fr)
WO (1) WO2001002393A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US7658913B2 (en) 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
CA2672971C (fr) * 2007-01-23 2014-03-11 Pharmagra Labs, Inc. Sulforaphane stabilise

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (fr) 1985-10-25 1993-08-04 Beecham Group Plc Dérivé de pipéridine, sa préparation et son utilisation comme médicament
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
CA2206592A1 (fr) 1996-05-30 1997-11-30 Shu-Zhong Wang Methode de preparation de chlorhydrate de paroxetine amorphe
US5672612A (en) 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
JP2001503406A (ja) * 1996-10-28 2001-03-13 ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ 医薬組成物
JPH10167958A (ja) * 1996-12-09 1998-06-23 Sankyo Co Ltd ロキソプロフェンナトリウム類を含有する口腔内速溶性製剤及びその製造方法
JPH10194996A (ja) * 1996-12-25 1998-07-28 Janssen Pharmaceut Nv アシル化シクロデキストリン含有製薬組成物
AP9901604A0 (en) 1997-01-15 1999-09-30 Smithkline Beecham Plc Paroxetine compositions.
ZA981558B (en) * 1997-02-27 1998-08-27 Novo Nordisk As Inclusion complexes in aqueous solution
HUP9700632A3 (en) * 1997-03-24 1999-10-28 Cyclolab Ciklodextrin Kutato F Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
EP0994872B9 (fr) * 1997-06-10 2001-12-05 Synthon B.V. Composes 4-phenylpiperidine
GB9724544D0 (en) 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
EP1102764A1 (fr) * 1998-08-08 2001-05-30 Smithkline Beecham Plc Sels de paroxetine

Also Published As

Publication number Publication date
EP1109806B8 (fr) 2003-10-29
KR100759159B1 (ko) 2007-09-14
CA2341984A1 (fr) 2001-01-11
ES2206254T3 (es) 2004-05-16
BR0006838A (pt) 2001-08-07
KR20010072880A (ko) 2001-07-31
EP1109806B1 (fr) 2003-08-27
US6984632B1 (en) 2006-01-10
JP2003503493A (ja) 2003-01-28
PT1109806E (pt) 2004-02-27
ATE248165T1 (de) 2003-09-15
WO2001002393A1 (fr) 2001-01-11
AU5535900A (en) 2001-01-22
DE60004768D1 (de) 2003-10-02
DE60004768T2 (de) 2004-07-08
EP1109806A1 (fr) 2001-06-27

Similar Documents

Publication Publication Date Title
HUP0101564A2 (hu) Epotilon készítmények
MA27040A1 (fr) Nucleosides substitues en 4'
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
DE69623449D1 (de) Thyroxine/zyklodextrinkomplexe und ihre pharmazeutische formulierung
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
CA2074186A1 (fr) Derives de cyclodextrines plus solubles dans l'eau et leur utilisation
TW200608972A (en) Aryl-pyridine derivatives
MY121999A (en) Inclusion complexes of aryl-heterocyclic salts
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
PT992509E (pt) Novos derivados macrolidos
ES2186186T3 (es) Derivados ariloxianilina.
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
EA200300406A1 (ru) Фармацевтическая композиция дронедарона для парентерального введения
DK1109806T3 (da) Komplekser af paroxetin med cyclodextriner eller cyclodextrinderivater
ATE280588T1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
ATE402140T1 (de) Cyclopentyl sulfonamid derivaten
ATE402179T1 (de) Indolderivate und deren verwendung in medikamenten
ITRM20030394A1 (it) Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche.
ATE299027T1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
BR9914125A (pt) Composições farmacêuticas baseadas em alfa-ciclodextrina para administração oral de análogos lh-rh
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
FR2797446B1 (fr) Derives de phenanthroline-7-ones et leurs applications en therapeutique
AU1584800A (en) Immuno-active, anti-cancer and pharmacologically active polysaccharide compoundsand pharmaceutical compositions containing the polysaccharide compounds
DK0952157T3 (da) 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin